Sequenom is the lead sponsor of 5 current clinical trials in our USA register. 4 are recruiting patients now. All registered phases are Observational. The most-studied condition is Pregnancy Related.
| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Non-Invasive Preeclampsia Screening and Biobank
NCT06643741 · ClinicalTrials.gov ↗ · Preeclampsia (PE)
|
Observational | Recruiting | 2025-02 | USA |
|
Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix
NCT07543757 · ClinicalTrials.gov ↗ · Prostate Cancer Detection
|
Observational | Recruiting | 2026-04 | USA |
|
Specimen Collection From Pregnant Women at Increased Risk for Fetal Aneuploidy
NCT01429389 · ClinicalTrials.gov ↗ · Down Syndrome, Fetal Aneuploidy
|
Observational | Recruiting | 2011-05 | USA |
|
Specimen Collection from Patients with Non-Hematologic Cancer for Use in Development of a Liquid Biopsy Assay
NCT02586389 · ClinicalTrials.gov ↗ · Non-hematologic Cancer
|
Observational | Recruiting | 2015-10 | USA |
|
Compliant Analysis of Patient Samples and Data
NCT04364503 · ClinicalTrials.gov ↗ · Pregnancy Related, Cancer, Infectious Disease
|
Observational | By invitation | 2018-03 | USA |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in USA | 5 | 4 |
A trial with sites in more than one country appears in each of those registers.
| Sponsor | Trials |
|---|---|
| Sumitomo Pharma Switzerland | 2 |
Sponsors with the most current trials registered for this condition.
Sequenom is the lead sponsor of 5 current trials on ClinicalTrials.gov in our USA register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 4 of its 5 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.